Amrutanjan Health Care Q3 Results
- BSE: 590006
- NSE: AMRUTANJAN
- ISIN: INE098F01031
- Sector: Biotechnology & Drugs
BSE
638.00
0.00 (0.00%)
0.00 (0.00%)Volume377.00
Updated: Fri 13 Feb, 2026 | 15:29:30
NSE
635.00-1.60 (-0.25%)
-1.60 (-0.25%)Volume4.89 K
Updated: Fri 13 Feb, 2026 | 15:30:03
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
- Total Income₹141.04 Cr.(14.90%)
- Operating Profit₹22.29 Cr.(2.80%)
- Profit After Tax₹19.45 Cr.(1.07%)
- Operating Margin15.81%(-10.53%)
Note: Comparison is on YoY basis
Quarterly - Amrutanjan Health Care Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 25 | Sep 24 | QoQ Comp | Dec 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 118.75 | 97.97 | 15.59% | 97.00 | 17.49% |
| Depreciation/ Amortization | 1.62 | 1.65 | 4.28% | 1.58 | -2.37% |
| Operating Income | 22.29 | 11.95 | 48.93% | 20.00 | 2.80% |
| Net Income | 19.45 | 11.80 | 39.33% | 17.45 | 1.07% |
| Other Operating Expenses Total | 14.59 | 12.48 | 5.56% | 13.17 | 18.22% |
| Net Income Before Taxes | 26.36 | 15.94 | 37.21% | 23.71 | 1.44% |
| Total Revenue | 141.04 | 109.92 | 19.83% | 116.99 | 14.90% |
| Selling/ General/ Admin Expenses Total | 37.49 | 29.43 | 26.22% | 25.68 | 19.91% |
| Diluted Normalized EPS | 7.05 | 4.08 | 45.95% | 6.04 | 5.85% |